Summary

Market Overview
The Europe voice restoration devices market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).
Voice restoration devices are devices or technologies used to help individuals who have lost the ability to speak due to injury or disease regain their ability to communicate verbally. These devices can include computer-based systems, electronic speech synthesizers, and other assistive technologies. They may also include surgical or medical treatments that can help to repair or restore damaged vocal cords or other parts of the voice production system.
Market Dynamics
Technological advancements, the aging population, an increase in chronic diseases, government funding and reimbursement policies, and growing awareness about the importance of communication drive the Europe voice restoration devices market growth.
Growing awareness about the importance of communication in European countries the market growth
Growing awareness about the importance of communication in European countries drives the market. European organizations and governments have been investing in education and awareness campaigns to educate the public about the importance of communication, the impact of speech impairments, and the benefits of using voice restoration devices. Also, the media is important in raising awareness about various health issues. The increased coverage of speech impairments and the use of voice restoration devices in the media has helped raise awareness about the importance of communication among the general public. Support groups and advocacy organizations for individuals with speech impairments have been actively working to raise awareness about the importance of communication and the benefits of using voice restoration devices.
Furthermore, changing societal attitudes towards individuals with speech impairments and recognizing the importance of communication for these individuals have contributed to the growing awareness about the importance of communication in Europe. In addition, technological advancements have led to the development of more advanced and sophisticated voice restoration devices, making them more accessible and affordable for individuals in Europe and creating more awareness about the importance of communication.
The risk factors associated with voice restoration devices will hamper the growth of the market
However, risk factors associated with voice restoration devices infection, collapsed lung (pneumothorax), endotracheal tube or stent displacement, voice and swallowing difficulties, and other common side effects, including side effects of anesthesia, include sore throat, shivering, sleepiness, dry mouth, nausea and vomiting. These effects are usually short-lived but could continue for several days. These factors are limiting the market growth.
COVID-19 Impact Analysis
The COVID-19 pandemic considerably affects the voice restoration devices market in European countries. As per the article published in the Journal of Otolaryngology-Head & Neck Surgery in 2020, laryngectomy patients with a tracheoesophageal puncture (TEP) use a voice prosthesis for vocal restoration require frequent specialized ongoing care during a pandemic. It is important to develop clear processes to support patients at risk for complications associated with TEP voice prosthesis use to guard their safety and reduce potential additional health system burden. Several recommendations have been published by institutions and societies on managing total laryngectomy patients during the COVID-19 pandemic.
In addition, during the pandemic, many people take online/video consultancy for their voice correction issues. The COVID-19 situation is recovering, and all patients can access healthcare facilities, which drives the voice restoration market in the European region. These factors are limiting the market growth.
Segment Analysis
The artificial larynx (electrolarynx) segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
The artificial larynx (electrolarynx) segment accounts for the highest market share. An electrolarynx is a battery-operated machine that produces sound for the user to create a voice. This small, battery-operated device is placed directly on the neck, under the chin, when the user wants to speak. When the user pushes a button on the device, the electrolarynx produces a vibration transferred through the skin to the throat. It can be shaped into words with the mouth, tongue, lips, and teeth. The sound created by an electrolarynx is electronic, but it can be well understood. Speech therapists can guide the user on using the device as a primary means of communication or as a backup to one of the other options.
In addition, the electrolarynx might be the best speech method for the user in case the user cannot have a voice prosthesis (TEP) for medical reasons, the user did not have a voice prosthesis put in at the time of surgery but is waiting to have one put in later.
Some of the machines have buttons to vary the pitch or tone of the sound made by the electronic larynx. This makes users' voices sound more varied. In addition, the speech and language therapist will advise the best type for the situation and can arrange for a user to have an electrolarynx on loan.
Geographical Analysis
U.K. region holds the largest market share of the Europe voice restoration devices market
U.K. dominates the market for voice restoration devices and is expected to show a similar trend over the forecast period. Technological advancements, the rising awareness of voice restoration, and active key players in the U.K. region drive the market.
As per the article published in Frontiers in 2020, in the U.K, for instance, there are approximately 500–600 laryngectomies performed each year. In the developing world, however, many laryngeal cancers are diagnosed at more advanced stages and require total laryngectomy.
In addition, Atos Medical is offering voice restoration devices in the European region. For instance, Provox Life offers a flexible and complete solution that allows user to experience a personalized regime, no matter where thee user is on their recovery journey.
Competitive Landscape
The voice restoration devices market is a moderately competitive presence of local and Europe companies. Some of the key players which are contributing to the growth of the market are Atos Medical (Coloplast), Inhealth Technologies, Freudenberg Medical, Smith’s Medical (ICU Medical), Sanova Holding AG, Orbisana Healthcare, William Demant Holdings, Johnson and Johnson, Orbisana Healthcare GmbH, and Andreas Fahl Medizintechnik Vertrieb GmbH, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the voice restoration devices market.
For instance,
• In July 2021, Atos acquired Heimomed Heinze GmbH & Co. KG, a med-tech organization that manufactures high-quality tracheostomy products.
Atos Medical (Coloplast)
Overview:
Coloplast produces products and services that make life easier for people with very personal and private medical conditions. The company Works closely with the people who use its products and create solutions sensitive to their special needs. The business includes Ostomy Care, Continence Care, Wound & Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally, and the organization is about 14,000 employees.
Product Portfolio:
Atos Medical legacy brand Provox: Provox, a legacy brand of Atos Medical, provides voice prostheses for speaking to laryngectomee patients, HMEs, adhesives, laryngectomy tubes for breathing, hands-free speaking gadgets, and accessories.
The Europe voice restoration devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

ページTOPに戻る

Table of Contents